These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 36379686)
1. Ten-year experience with intracameral chemotherapy for aqueous seeding in retinoblastoma: long-term efficacy, safety and toxicity. Stathopoulos C; Beck-Popovic M; Moulin AP; Munier FL Br J Ophthalmol; 2023 Dec; 108(1):124-130. PubMed ID: 36379686 [TBL] [Abstract][Full Text] [Related]
2. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture. Shields CL; Douglass AM; Beggache M; Say EA; Shields JA Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience. Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679 [TBL] [Abstract][Full Text] [Related]
4. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma. Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622 [TBL] [Abstract][Full Text] [Related]
6. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma. Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients. Bogan CM; Pierce JM; Doss SD; Tao YK; Chen SC; Boyd KL; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB Exp Eye Res; 2021 Mar; 204():108439. PubMed ID: 33444583 [TBL] [Abstract][Full Text] [Related]
8. Intravitreal injection of melphalan for intraocular retinoblastoma. Suzuki S; Aihara Y; Fujiwara M; Sano S; Kaneko A Jpn J Ophthalmol; 2015 May; 59(3):164-72. PubMed ID: 25808017 [TBL] [Abstract][Full Text] [Related]
9. Management of cataracts secondary to intravitreal chemotherapy injections for retinoblastoma seeding. Koç İ; Taylan Şekeroğlu H; Kıratlı H; Lotfisadigh S Eur J Ophthalmol; 2022 May; 32(3):1766-1771. PubMed ID: 34082595 [TBL] [Abstract][Full Text] [Related]
10. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds. Lee JH; Han JW; Hahn SM; Lyu CJ; Kim DJ; Lee SC Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma. Francis JH; Abramson DH; Gobin YP; Marr BP; Tendler I; Brodie SE; Dunkel IJ Ophthalmology; 2015 May; 122(5):1016-22. PubMed ID: 25616769 [TBL] [Abstract][Full Text] [Related]
12. Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience. Akyüz C; Kıratlı H; Şen H; Aydın B; Tarlan B; Varan A Ophthalmologica; 2015; 234(4):227-32. PubMed ID: 26368674 [TBL] [Abstract][Full Text] [Related]
13. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy. Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423 [TBL] [Abstract][Full Text] [Related]
14. Addition of intravitreal carboplatin with melphalan for management of vitreous seeding in retinoblastoma. Riazi-Esfahani H; Masoomian B; Khodabandeh A; Amini A; Taghizadeh S; Boujabadi L; Sharifkashani S; Shields CL; Ghassemi F Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):1167-1175. PubMed ID: 36401651 [TBL] [Abstract][Full Text] [Related]
15. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era. Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma. Ghassemi F; Shields CL Arch Ophthalmol; 2012 Oct; 130(10):1268-71. PubMed ID: 23044940 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study. Bogan CM; Kaczmarek JV; Pierce JM; Chen SC; Boyd KL; Calcutt MW; Bridges TM; Lindsley CW; Nadelmann JB; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB Br J Ophthalmol; 2022 Feb; 106(2):288-296. PubMed ID: 33972235 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment of ciliary body medulloepithelioma with intraocular melphalan chemotherapy: a case report. Stathopoulos C; Gaillard MC; Schneider J; Munier FL BMC Ophthalmol; 2020 Jun; 20(1):239. PubMed ID: 32552699 [TBL] [Abstract][Full Text] [Related]
19. Pathological findings in enucleated eyes after intravitreal melphalan injection. Ghassemi F; Amoli FA Int Ophthalmol; 2014 Jun; 34(3):533-40. PubMed ID: 24043335 [TBL] [Abstract][Full Text] [Related]
20. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma. Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]